Pulse Biosciences

$21.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-0.95%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PLSE and other stocks, options, and ETFs commission-free!

About PLSE

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling.

CEO

Darrin R. Uecker

Employees

Headquarters

Hayward, California

Founded

2014

Market Cap

591.18M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

91.77K

High Today

$22.09

Low Today

$21.25

Open Price

$22.09

Volume

59.91K

52 Week High

$45.82

52 Week Low

$6.21

PLSE Earnings

-$0.66

-$0.44

-$0.22

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 10, After Hours